X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8656) 8656
Magazine Article (46) 46
Book / eBook (6) 6
Conference Proceeding (6) 6
Book Chapter (4) 4
Dissertation (3) 3
Publication (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anti-ulcer agents - therapeutic use (7316) 7316
humans (7198) 7198
science & technology (4889) 4889
male (4875) 4875
life sciences & biomedicine (4859) 4859
female (4007) 4007
middle aged (3080) 3080
adult (2865) 2865
gastroenterology & hepatology (2218) 2218
omeprazole - therapeutic use (2189) 2189
aged (2094) 2094
helicobacter infections - drug therapy (2036) 2036
pharmacology & pharmacy (1865) 1865
animals (1757) 1757
helicobacter pylori (1613) 1613
drug therapy, combination (1505) 1505
treatment outcome (1474) 1474
anti-ulcer agents - administration & dosage (1470) 1470
proton pump inhibitors (1362) 1362
stomach ulcer - drug therapy (1274) 1274
anti-ulcer agents - pharmacology (1252) 1252
anti-bacterial agents - therapeutic use (1251) 1251
peptic ulcer - drug therapy (1194) 1194
rats (1177) 1177
duodenal ulcer - drug therapy (1121) 1121
abridged index medicus (987) 987
gastroesophageal reflux - drug therapy (958) 958
2-pyridinylmethylsulfinylbenzimidazoles (914) 914
anti-ulcer agents - adverse effects (900) 900
adolescent (857) 857
histamine h2 antagonists - therapeutic use (850) 850
omeprazole - analogs & derivatives (843) 843
double-blind method (808) 808
gastric mucosa - drug effects (755) 755
amoxicillin - therapeutic use (733) 733
helicobacter pylori - drug effects (707) 707
lansoprazole (706) 706
stomach ulcer - chemically induced (703) 703
ranitidine - therapeutic use (689) 689
time factors (675) 675
prospective studies (669) 669
clarithromycin - therapeutic use (630) 630
helicobacter infections - complications (625) 625
anti-inflammatory agents, non-steroidal - adverse effects (622) 622
recurrence (618) 618
omeprazole - administration & dosage (602) 602
omeprazole (600) 600
stomach ulcer - prevention & control (579) 579
general & internal medicine (575) 575
dose-response relationship, drug (555) 555
aged, 80 and over (553) 553
gastric mucosa - pathology (530) 530
medicine, general & internal (518) 518
risk factors (511) 511
rats, wistar (510) 510
follow-up studies (481) 481
clinical trials as topic (476) 476
antacids - therapeutic use (454) 454
hydrogen-ion concentration (442) 442
metronidazole - therapeutic use (420) 420
helicobacter infections - microbiology (416) 416
stomach ulcer - pathology (415) 415
cimetidine - therapeutic use (395) 395
helicobacter pylori - isolation & purification (387) 387
drug administration schedule (383) 383
benzimidazoles - therapeutic use (382) 382
gastric acid - secretion (381) 381
plant extracts - therapeutic use (377) 377
peptic ulcer (374) 374
medicine & public health (369) 369
administration, oral (361) 361
duodenal ulcer - microbiology (358) 358
disease models, animal (355) 355
gastroesophageal reflux - complications (352) 352
proton pump inhibitors - therapeutic use (343) 343
chemistry, medicinal (342) 342
peptic ulcer - microbiology (340) 340
organometallic compounds - therapeutic use (335) 335
bismuth - therapeutic use (334) 334
gastritis - drug therapy (333) 333
mice (333) 333
peptic ulcer - prevention & control (328) 328
dyspepsia - drug therapy (327) 327
helicobacter infections - diagnosis (325) 325
omeprazole - adverse effects (321) 321
anti-bacterial agents - administration & dosage (316) 316
care and treatment (315) 315
child (311) 311
gastroesophageal reflux (304) 304
anti-ulcer agents - pharmacokinetics (303) 303
gastric mucosa - metabolism (303) 303
rabeprazole (302) 302
gastric acid - metabolism (300) 300
rats, sprague-dawley (293) 293
enzyme inhibitors - therapeutic use (292) 292
plant extracts - pharmacology (292) 292
ulcers (291) 291
gastroesophageal reflux - diagnosis (289) 289
2-pyridinylmethylsulfinylbenzimidazoles - therapeutic use (278) 278
anti-inflammatory agents, non-steroidal - therapeutic use (276) 276
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7362) 7362
Russian (468) 468
German (275) 275
Japanese (232) 232
Spanish (207) 207
French (180) 180
Chinese (96) 96
Italian (80) 80
Portuguese (35) 35
Dutch (30) 30
Polish (29) 29
Korean (24) 24
Romanian (21) 21
Ukrainian (20) 20
Danish (18) 18
Hungarian (14) 14
Hebrew (13) 13
Bulgarian (10) 10
Czech (10) 10
Swedish (8) 8
Finnish (7) 7
Croatian (5) 5
Norwegian (4) 4
Serbian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Digestion, ISSN 0012-2823, 01/2017, Volume 94, Issue 4, pp. 240 - 246
Journal Article
Cancer, ISSN 0008-543X, 05/2014, Volume 120, Issue 10, pp. 1453 - 1461
Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational... 
gastrointestinal | mucositis | guidelines | oral | stomatitis | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) | Life Sciences & Biomedicine | Oncology | Science & Technology | Sucralfate - administration & dosage | Humans | Radiotherapy - adverse effects | Antineoplastic Agents - administration & dosage | Protective Agents - therapeutic use | Mucositis - prevention & control | Proctitis - prevention & control | Antineoplastic Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Neoplasms - radiotherapy | Intercellular Signaling Peptides and Proteins - administration & dosage | Low-Level Light Therapy | Esophagitis - therapy | Analgesics - therapeutic use | Proctitis - therapy | Anti-Infective Agents - therapeutic use | Evidence-Based Medicine | Mucositis - therapy | Cytokines - administration & dosage | Esophagitis - etiology | Stomatitis - etiology | Mucositis - chemically induced | Oral Hygiene | Anti-Ulcer Agents - administration & dosage | Neoplasms - drug therapy | Phototherapy | Stomatitis - therapy | Proctitis - etiology | Mucositis - etiology | Stomatitis - chemically induced | Esophagitis - prevention & control | Radiation-Protective Agents - therapeutic use | Stomatitis - prevention & control | Amifostine - therapeutic use | Cryotherapy | Hyperbaric Oxygenation | Practice guidelines (Medicine) | Usage | Care and treatment | Mucositis | Analysis | Cancer | Index Medicus | Abridged Index Medicus | ISOO | Review | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 6, pp. 1158 - 1165
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2001, Volume 344, Issue 13, pp. 967 - 973
Journal Article
Journal of neuro-oncology, ISSN 0167-594X, 3/2009, Volume 92, Issue 1, pp. 33 - 35
Temozolomide (TMZ) is a cytotoxic agent of the imidazotetrazine class, chemically related to dacarbazine... 
Oncology | Opportunistic infections | Temozolomide | Medicine & Public Health | Lymphopenia | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Dacarbazine - adverse effects | Red-Cell Aplasia, Pure - drug therapy | Heptanoic Acids - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Pulmonary - chemically induced | Dacarbazine - analogs & derivatives | Anti-Inflammatory Agents - therapeutic use | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Fluoxetine - therapeutic use | Pyrroles - therapeutic use | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Anti-Infective Agents - therapeutic use | Anticonvulsants - therapeutic use | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Brain Neoplasms - drug therapy | Radiotherapy | Pyrazinamide - therapeutic use | Atorvastatin Calcium | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Phenobarbital - therapeutic use | Anticholesteremic Agents - therapeutic use | Antibiotics, Antitubercular - therapeutic use | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Prednisone - therapeutic use | Online health care information services | Pneumonia | Tuberculosis | Gliomas | Analysis | Bacterial pneumonia | Brain tumors | Pyrazinamide | Health aspects | Rifampin | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9573, pp. 1621 - 1626
... for the management of osteoarthritis and an international working group on pain management recommend use of COX 2 inhibitors or the combination of NSAIDs and a PPI in patients... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrazoles - therapeutic use | Humans | Esomeprazole - adverse effects | Male | Secondary Prevention | Osteoarthritis - drug therapy | Esomeprazole - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Female | Drug Therapy, Combination | Pyrazoles - adverse effects | Anti-Ulcer Agents - therapeutic use | Double-Blind Method | Proton Pump Inhibitors | Risk Factors | Anti-Ulcer Agents - adverse effects | Peptic Ulcer Hemorrhage - chemically induced | Treatment Outcome | Celecoxib | Peptic Ulcer Hemorrhage - therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Sulfonamides - adverse effects | Aged | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - therapeutic use | Prevention | Complications and side effects | COX-2 inhibitors | Relapse | Gastrointestinal bleeding | Peptic ulcer | Proton pump inhibitors | Dosage and administration | Drug therapy | Diseases | Drugs | Medical research | Physical examinations | Hospitals | Analgesics | Ulcers | Terminal illnesses | Clinical trials | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article